Category

China

China: SenseTime Group, Guodian Technology & Environment Group, Huitongda, Peijia Medical, Asia High Yield Bond Index, Beijing Yuanxin Technology Group Co Ltd, OrbusNeich Medical Group, MicroPort NeuroTech and more

By | China, Daily Briefs

In today’s briefing:

  • HSCI Index Rebalance and Stock Connect: Plenty of New Listings Should Be Included
  • Guodian Tech’s Privatisation Offer
  • Huitongda IPO: Huge Churn Rate Indicates That Things Could Go Bad Very Quickly
  • Peijia Medical (9996.HK) Vs Venus MedTech (2500.HK) Vs CardioFlow (2160.HK)-Pain Points and Solution
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers
  • Beijing Yuanxin (北京圆心) Pre-IPO – Growing at the Expense of Margins
  • Pre-IPO OrbusNeich Medical Group: A Scale Player, With Comprehensive Portfolio in PCI Balloon Market
  • Microport NeuroTech (微创脑科学) Pre-IPO: Decent Name for Neuro-Interventional Devices

HSCI Index Rebalance and Stock Connect: Plenty of New Listings Should Be Included

By Brian Freitas

  • The review period for the March review of the HSCI ended on 31 December. There are a lot of new listings that should be included in the index.
  • SenseTime is a high probability inclusion to the index, though it will only be added to Stock Connect in July once it completes 6 months and 20 trading days.
  • Xpeng and Li Auto will be added to Stock Connect in Feb/March if they pass the velocity test. We see Li Auto as failing the test, while Xpeng is close.

Guodian Tech’s Privatisation Offer

By Arun George

  • Guodian Technology & Environment Group (1296 HK) announced a pre-conditional privatisation offer from China Energy at HK$1.08 per H share, a 47.59% premium to the last close. 
  • The key conditions for the delisting will be approval by at least 75% independent H-shareholders (<10% of all independent H-shareholders rejection). There is no minimum acceptance condition.  
  • The offer is attractive in comparison to long-term historical share prices and multiples. We think that the privatisation proposal will likely succeed. 

Huitongda IPO: Huge Churn Rate Indicates That Things Could Go Bad Very Quickly

By Oshadhi Kumarasiri

  • Alibaba Group (9988 HK) backed B2B e-commerce business, Huitongda (1566215D CH) is looking to go public to raise $500m to save the business.
  • With churn rates as high as 50%, things could get ugly rather quickly if customer acquisition falls below sub optimal levels.
  • We fear this is an attempt to save a failing business that could be worthless in few years.

Peijia Medical (9996.HK) Vs Venus MedTech (2500.HK) Vs CardioFlow (2160.HK)-Pain Points and Solution

By Xinyao (Criss) Wang

  • Venus MedTech (2500 HK) is taking the lead in TAVR industry, but Peijia Medical (9996 HK) has advantages in development progress of future products. So, the market pattern is not yet determined.
  • The high cost of TAVR surgery is the main reason for lower-than-expected sales performance of related companies and low market penetration. The fierce competition would also bring more challenges. 
  • A good solution is to enter developing markets with CE mark, which would offer a new commercialization option and also a wider expansion beyond just European and American markets.

Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

US equity markets dropped yet another day on Friday, with the S&P and Nasdaq down 1.9% and 2.7% as the risk-off sentiment continued to weigh on markets. Most sectors were in the red with Communication Services and Consumer Discretionary down 3.1% and 3.9%. US 10Y Treasury yields were flat at 1.77% after easing 8bp on Thursday. European markets closed mostly higher with the DAX and CAC down 1.9%, 1.8% and 1.2%. Brazil’s Bovespa closed 0.2% lower. In the Middle East, UAE’s ADX was up 0.3% and Saudi TASI was down 1.1%. Asian markets have broadly opened in the red – HSI, STI and Nikkei were down 1%, 0.1%, 0.6% while Shanghai was up 0.2%. US IG CDS spreads were 1.1bp wider and HY CDS spreads were 5.7bp wider, EU Main CDS spreads were 1.7bp wider and Crossover CDS spreads were 7.9bp wider. Asia ex-Japan CDS spreads were 1.5bp wider.

Beijing Yuanxin (北京圆心) Pre-IPO – Growing at the Expense of Margins

By Sumeet Singh

  • Beijing Yuanxin Tech (BYT) is looking to raise US$500m in its upcoming Hong Kong IPO.
  • As per F&S, the firm is the No. 1 integrated healthcare fulfilment platform in China focusing on prescription drugs
  • In this note, we look at the company’s fundamentals and operations and share our thoughts about the IPO.

Pre-IPO OrbusNeich Medical Group: A Scale Player, With Comprehensive Portfolio in PCI Balloon Market

By Tina Banerjee

  • OrbusNeich Medical Group focuses on coronary and peripheral interventional instruments, such as balloons and stents used in PCI (coronary)/PTA (peripheral) procedures.
  • Comprehensive and innovative product portfolio for endovascular interventional procedures, established global sales network, and robust pipeline are the major strength of OrbusNeich.
  • Fierce competition, commoditized nature of the offering, centralized procurement leading to substantial price drop are some of the concerns for the company.

Microport NeuroTech (微创脑科学) Pre-IPO: Decent Name for Neuro-Interventional Devices

By Ke Yan, CFA, FRM

  • Microport NeuroTech is a leading neuro-interventional device company in China. The company is looking to raise up to USD 300m via a Hong Kong listing.
  • We look at the company’s key segments and products. We like the company’s comprehensive coverage of neuro-interventional devices.
  • Its management team has decent experience as it is a spin-off from Microport. We also highlight the risk of the stock.

Before it’s here, it’s on Smartkarma

China: Bank Of Ningbo Co Ltd A, China Mobile, Evergrande, Remegen Co Ltd and more

By | China, Daily Briefs

In today’s briefing:

  • FTSE China A50 Index Rebalance Preview (March 2022): Adds, Deletes & FOL Changes
  • China Mobile Parent Ups The Ante – Announces Share Increase Plan
  • China Evergrande Group – Vultures Circling
  • Pre-IPO Remegen Co Ltd – Some Points Worth the Attention

FTSE China A50 Index Rebalance Preview (March 2022): Adds, Deletes & FOL Changes

By Brian Freitas

  • We see three potential changes at the March rebalance. One is a high probability change while the other two are close to the cutoff ranks.
  • Then there will be changes to the investability weight of the stocks following the Ground Rule change that will cap stocks at their Foreign Ownership Limits.
  • The combined impact of all changes at the rebalance will result in a one-way turnover estimated at 17.55% and will result in a one-way trade of CNY 9,744m.

China Mobile Parent Ups The Ante – Announces Share Increase Plan

By Travis Lundy

  • The parent company of China Mobile (941 HK) has announced a plan to increase its holding. This is not surprising given the contents of the RMB Share Issue Circular.
  • If they spend the midpoint of the RMB 3.0-5.0bn plan at a 20+% premium to current price, it is 8% of the RMB Share float. 
  • The H-share buyback program is eligible to start after 8 Feb deadline for RMB Share greenshoe allocation. The stock is HK$51. Anything under HK$70/share is accretive vs the IPO.

China Evergrande Group – Vultures Circling

By Thomas J. Monaco

  • Mainland Chinese municipalities and authorities continue to find numerous ways to bone pick the Evergrande carcass without compensation; 
  • Evergrande’s offshore bondholders are now threatening legal enforcement of collateral over the company’s “opaque” debt restructuring process; and
  • Guangdong province is seeking to segregate Evergrande’s offshore assets in a fire sale to cover what they can of the company’s offshore debt. 

Pre-IPO Remegen Co Ltd – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • RC48’s commercialization performance in China market could be lower than expected. The breakthrough point is whether the deal with Seagen can bring any surprise in the global markets.
  • Due to large R&D and selling expenses, Remegen Co Ltd (9995 HK) is facing cash flow pressure, indicating that this IPO in SSE STAR market is very important for the Company.
  • Let’s see if RemeGen would in-license some unique late-stage candidates or reach new blockbuster license-out deals that surprise us again, both of which would help turn things around.

Before it’s here, it’s on Smartkarma

China: Dragon Crown Group, Luckin Coffee, China South City, Asia High Yield Bond Index and more

By | China, Daily Briefs

In today’s briefing:

  • Dragon Crown (935 HK): Offeror’s IFA Report
  • Luckin Coffee Relisting: Could Be Another Attempt to Deceive Investors
  • Weekly Wrap – 21 Jan 2022
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

Dragon Crown (935 HK): Offeror’s IFA Report

By David Blennerhassett


Luckin Coffee Relisting: Could Be Another Attempt to Deceive Investors

By Oshadhi Kumarasiri

  • Following an improvement in the financial performance, The FT reported that Luckin Coffee (LKNCY US) is plotting to relist its shares in the US sometime this year.
  • Although financials have improved, relisting seems a bit premature, especially since Luckin is still not a completely clean house.
  • This relisting feels a bit like another attempt by the ex-chairman to deceive minority investors to get the best possible exit price.

Weekly Wrap – 21 Jan 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. Sunac China Holdings
  2. Anton Oilfield
  3. Olam International
  4. Times China
  5. Shimao Property Holdings

and more…


Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

US equity markets dropped yet another day with the S&P and Nasdaq down 1.1% and 1.3% as risk-off sentiment continued to weigh on markets. Most sectors were in the red with Consumer Discretionary, Materials and IT down 1.3-1.9%. US 10Y Treasury yields eased 8bp to 1.77%. European markets closed mostly higher with the DAX and CAC up 0.7% and 0.3% while FTSE was down 0.1%. Brazil’s Bovespa closed 1% higher. In the Middle East, UAE’s ADX and Saudi TASI were up 0.8% and 0.3%. Asian markets have opened in the red – Shanghai, HSI, STI and Nikkei were down 0.8%, 0.6%, 0.1% and 1.4%. US IG CDS spreads were 1.6bp wider and HY CDS spreads were 7bp wider, EU Main CDS spreads were 0.1bp tighter and Crossover CDS spreads were 0.6bp tighter. Asia ex-Japan CDS spreads were 1.6bp wider.

Before it’s here, it’s on Smartkarma

China: Swire Pacific (A), FTSE China A50 Index, ClouDr Group, Kuaishou Technology, China South City, Asia High Yield Bond Index and more

By | China, Daily Briefs

In today’s briefing:

  • StubWorld: Cathay Pacific – Still Grounded
  • China/HK Breakout Points Need Follow Through
  • ClouDr (智云健康) Pre-IPO – Strong Growth but Has Issues that Need to Be Clarified
  • Kuaishou (1024 HK): Right Decision to Cut Costs, Still 20% Upside After 13% Rise
  • Morning Views Asia: China South City, Sunac China Holdings
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

StubWorld: Cathay Pacific – Still Grounded

By David Blennerhassett

  • Cathay Pacific Airways (293 HK) dangles bonuses for pilots and first officers amid Hong Kong’s stringent crew quarantine requirements. 
  • Preceding my comments on Cathay – and Swire Pacific (A) (19 HK)– are the current setup/unwind tables for Asia-Pacific Holdcos. 
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

China/HK Breakout Points Need Follow Through

By Thomas Schroeder

  • A share bull wedge stands out after meeting the 15k downside target. H shares bullish near lower wedge support.
  • The cut in key lending rates is spurring a push in HK/China, one needs to make sure this is not just another flash in the pan given a weak SPX.
  • HSI impulse out of bull flag cleared wedge resistance and needs resolution. On watch to close higher level shorts.

ClouDr (智云健康) Pre-IPO – Strong Growth but Has Issues that Need to Be Clarified

By Clarence Chu

  • ClouDr Group (16897333D CH) (CDG) is looking to raise up to US$500m in its upcoming Hong Kong IPO.
  • The firm is a digital chronic condition management solution provider and is market leader in China in terms of the number of SaaS installations in hospitals and pharmacies in 2020.
  • In this note, we share our thoughts on the company’s business, financials, and operating metrics.

Kuaishou (1024 HK): Right Decision to Cut Costs, Still 20% Upside After 13% Rise

By Ming Lu

  • The stock price has risen 13% since our last note, but we still believe there is an upside of 21%.
  • The company is cutting employee benefits, from housing allowance to afternoon tea.
  • We believe the operating loss will shrink significantly in the following two years.

Morning Views Asia: China South City, Sunac China Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

US equity markets dropped again after with the S&P and Nasdaq down 1% and 1.2%. The latter is down 10% from its November 2021 high. Most sectors were in the red with Consumer Discretionary, Financials and IT down 1.4-1.8%. US 10Y Treasury yields eased 3bp to 1.85%. European markets closed higher with the DAX, CAC and FTSE up 0.2%, 0.6% and 0.4% respectively. Brazil’s Bovespa closed 1.3% higher. In the Middle East, UAE’s ADX and Saudi TASI were up 1.6% and 0.5%. Asian markets have opened broadly higher – HSI, STI and Nikkei were up 1.9%, 0.1% and 0.5% while Shanghai was down 0.2%. US IG CDS spreads were 0.6bp wider and HY CDS spreads were 3.5bp wider, EU Main CDS spreads were 0.1bp tighter and Crossover CDS spreads were 1.7bp tighter. Asia ex-Japan CDS spreads were 4.7bp tighter.

Before it’s here, it’s on Smartkarma

China: Aquila Acquisition Corporation, Country Garden Holdings Co, Aier Eye Hospital Group, Yuzhou Group and more

By | China, Daily Briefs

In today’s briefing:

  • Aquila Acquisition Corporation: Hong Kong’s CMB-Backed SPAC
  • Country Garden (2007 HK) – Top of Mind Questions for Mgmt
  • Aier Eye Hospital Group (300015.CH) – More than Just Bribery Scandal
  • Morning Views Asia: Anton Oilfield, Delta Dunia Makmur, Yuzhou Group

Aquila Acquisition Corporation: Hong Kong’s CMB-Backed SPAC

By David Blennerhassett

  • Aquila Acquisition Corporation (AAC HK), a SPAC backed by China Merchants Bank, has applied for listing in Hong Kong.
  • Aquila is the first SPAC company to seek listing since new rules allowing such listings came into effect on the 1 January 2022. 
  • Aquila is targeting technology-enabled companies in “new economy” sectors (such as green energy, life sciences, advanced technology and manufacturing) in Asia, with a focus on China.

Country Garden (2007 HK) – Top of Mind Questions for Mgmt

By Jason Yap, CFA

  • Country Garden is widely seen as one of the few remaining large and better quality developers
  • However, its share and bond prices fell sharply following a reportedly failed USD300 billion convertible bond capital raising effort, triggering investor concerns  
  • In this Insight, we highlight the top of mind questions for Country Garden’s management

Aier Eye Hospital Group (300015.CH) – More than Just Bribery Scandal

By Xinyao (Criss) Wang

  • According to public news, the recent bribery scandal of Aier Eye Hospital Group (300015 CH) has raised widespread concern. Shenzhen stock Exchange also issued a letter of inquiry.
  • The development model based on M&A funds helps rapid expansion, but also leads to profit orientation and large goodwill balance, indicating potential risks.
  • The biggest risk is the revolutionary technology/drugs to disrupt the business value of Aier’s medical services. So, Aier could be a short-term trade, but not a long-term hold. 

Morning Views Asia: Anton Oilfield, Delta Dunia Makmur, Yuzhou Group

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

China: HKEX, Citic Securities (H), Hongkong & Shanghai Hotels, XPeng, Yorkey Optical International Cayman, Dong E E Jiaoco Ltd A, Asia High Yield Bond Index, Agile Property Holdings, Wanda Commercial Management Group and more

By | China, Daily Briefs

In today’s briefing:

  • CCASS: Why Large Moves Still Mattered in 2021
  • The Citic Securities Rights Offering – Dilution Against Timing
  • HK&S Hotels (45 HK): Kadoories Mop Up Someone Else’s Mess
  • Xpeng: Milestone Year Ahead
  • HKEx (388.HK): Soft 4Q21 Trading Volume; Expect Muted Quarterly Earning Results
  • Yorkey Optical (2788 HK): Court Meeting On 22 Feb. IFA Says Fair
  • Dong E E Jiao (000423.CH) – Could the New Chairman Turn Things Around?
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers
  • Morning Views Asia: Olam International
  • Wanda Commercial Management Pre-IPO – The Negatives – Parents Leverage Status Will Be an Overhang

CCASS: Why Large Moves Still Mattered in 2021

By David Blennerhassett

  • In this latest installment in a series dating back to March 2018, I’ve analysed 4,400 moves over three years inside CCASS, targeting >5% of shares outstanding of individual stocks. 
  • The data continues to bear out the overall underperformance of stocks that exhibit large CCASS moves. 
  • But it also serves to illustrate that when a certain % move takes place in tandem with a certain market capitalisation, there is a tendency for outperformance. 

The Citic Securities Rights Offering – Dilution Against Timing

By Travis Lundy

  • Citic Securities has launched a Rights Offering for H Shares and A Shares. The price is basically the same, which means a very big discount for A holders.
  • The timing is different, and the H share Rights Issue process is drawn out past Chinese New Year. This may affect takeup rates and bullishness.
  • The difference in capital approach between Dual H/A-share listed SOEs like Citic Securities and like China Mobile is stark. The dichotomy may expand. 

HK&S Hotels (45 HK): Kadoories Mop Up Someone Else’s Mess

By David Blennerhassett

  • The Kadoorie family, Hongkong & Shanghai Hotels (45 HK)‘s major shareholder, is paying HK$2.63bn to increase its holding to 72.43% from 59.98%.
  • The price under the SPA is $12.80/share, a 92.5% premium to the undisturbed price. Shares promptly gained 19.5% yesterday. No Offer was triggered. 
  • What is conveniently left out of the announcement, and in media articles, is the original owner of these shares – Tai United Holdings (718 HK).

Xpeng: Milestone Year Ahead

By Victoria Li

  • Short term interruption from chips and LFP battery shortage would be eased in 2H2022.
  • Xpeng’s monthly delivery would ramp up to 30,000 cars with the launch of G9 in 3Q2022.
  • We estimate Xpeng’s net profit will turn positive at the end of 2022, which would trigger further re-rating of the stock to HK$300 (or US$77).

HKEx (388.HK): Soft 4Q21 Trading Volume; Expect Muted Quarterly Earning Results

By Roger Xie

  • 2021 full year ADT has grown 29% year-over-year compared with 2020. Trading activities in December continued to slowdown to year-end given the relative weak market sentiment and policy uncertainty.
  • We expect HKEX (388 HK) upcoming quarterly earning release (on Feb. 24) will be muted and estimate its 4Q21 revenue and profit will decline 3% and 7% year-over-year respectively. 
  • However, we remain bullish on HKEX (388 HK) with the view that China economy will likely rebound in 2022, which will drive the rebound of IPO activities and trading volume.

Yorkey Optical (2788 HK): Court Meeting On 22 Feb. IFA Says Fair

By David Blennerhassett

  • Yorkey Optical International Cayman (2788 HK)‘s Scheme Document is now out, with the Court Meeting to be held on the 22 February.
  • Asia Optical (3019 TT) is offering HK$0.999/share, a 75.3% premium to the undisturbed close. David Webb has given an irrevocable undertaking to vote his shares in favour of the Scheme 
  • This transaction is all stitched up. The Independent Financial Advisor considers the terms to be fair and reasonable. 

Dong E E Jiao (000423.CH) – Could the New Chairman Turn Things Around?

By Xinyao (Criss) Wang

  • The high price of EJiao discouraged consumers, leading to increasing inventory backlog in the distribution channel and reduction in payment collection, which finally resulted in Dong-E-E-Jiao’s net loss in 2019.
  • Although the performance has showed a recovery trend since 2020,concerns on raw material shortage, low inventory turnover, single product structure, high selling expense ratio and fierce market competition still remain.
  • There is still a long way to go for the Company to get back to peak, so we are conservative about Dong E E Jiaoco Ltd A (000423 CH)’s outlook.

Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

US equity markets were closed on Monday on account of Martin Luther King Jr. Day. US 10Y Treasury yields rose 14bp to 1.85% over increased expectations of a Fed rate hike in March. European markets closed higher on Monday with the DAX, CAC and FTSE up 0.3%, 0.8% and 0.9% respectively. Brazil’s Bovespa closed 0.5% lower. In the Middle East, UAE’s ADX was 0.15% lower while Saudi TASI was up 0.46%. Asian markets have opened broadly higher – Shanghai, STI and Nikkei are up 0.9%, 0.2% and 0.4% while HSI is down 0.1%. US IG and HY CDS spreads were unchanged, EU Main CDS spreads were 0.5bp wider and Crossover CDS spreads were 1.7bp wider. Asia ex-Japan CDS spreads widened 3.9bp.

Morning Views Asia: Olam International

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Wanda Commercial Management Pre-IPO – The Negatives – Parents Leverage Status Will Be an Overhang

By Sumeet Singh

  • Wanda Commercial Management Group (WCMG) is looking to raise up to US$4bn in its upcoming Hong Kong IPO.
  • WCMG is a commercial operation service provider. As of Oct 2021, the firm managed 398 malls with total gross floor area (GFA) under management of 56.5m sqm.
  • In this note, we will talk about the not so positive aspects of the deal.

Before it’s here, it’s on Smartkarma

China: AKM Industrial, Qingdao Ainnovation Technology Group Co Ltd, Air China Ltd (H), Asia High Yield Bond Index, China South City, Wanda Commercial Management Group, Shenzhen Chipscreen Biosciences-A and more

By | China, Daily Briefs

In today’s briefing:

  • AKM Industrial (1639 HK): SASAC and Xiamen Government-Backed Pre-Conditional Offer
  • Qingdao AInnovation Technology Group IPO – Fairly Valued with Mediocre Cornerstones
  • AInnovation Technology IPO: Valuation Insights
  • Air China (753 HK): Down but Not Out
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers
  • Morning Views Asia: China South City, Times China
  • Wanda Commercial Management Group Pre-IPO – The Positives – Aiming for One of HK’s Largest 2022 IPOs
  • Shenzhen Chipscreen Biosciences (688321.CH) – Risks Outweigh Opportunities

AKM Industrial (1639 HK): SASAC and Xiamen Government-Backed Pre-Conditional Offer

By David Blennerhassett

  • Flexible printed board player Akm Industrial (1639 HK) has announced a pre-conditional Scheme from Alpha Luck and AKM Meadville at HK$1.82/share. The Offer price will NOT be increased.
  • Alpha Luck is ultimately held by SASAC and AKM Meadville by the government of Haicang District, Xiamen. The two intend to hold 40:60 respectively in the unlisted vehicle. 
  • Various PRC regulatory approvals are required. This appears a transaction geared to complete. Timing is the key risk to the deal.

Qingdao AInnovation Technology Group IPO – Fairly Valued with Mediocre Cornerstones

By Clarence Chu

  • Qingdao Ainnovation Technology Group Co Ltd (1853807D CH) is looking to raise up to US$157m in its Hong Kong IPO.
  • Qingdao AInnovation Technology Group is an AI solutions provider offering full-stack AI-based products and solutions. 
  • While we don’t have a fundamental issue with the listing, at asking valuations, the firm appears to be fairly valued with limited upside on its FY23 numbers. 

AInnovation Technology IPO: Valuation Insights

By Arun George

  • AInnovation Technology (AIT HK) is a fast-growing enterprise AI solutions provider in China. It has launched an HKEx IPO to raise up to US$157 million. 
  • In AInnovation Technology IPO Initiation: Code Amber, we stated that the negatives outweigh the positives and we would give the IPO a pass.
  • Our valuation analysis suggests that the IPO price is fair. Due to our concerns about the fundamentals, we remain on the sidelines. Pricing is 20 January, listing on 27 January.

Air China (753 HK): Down but Not Out

By Osbert Tang, CFA

  • Passenger traffic momentum of Air China Ltd (H) (753 HK) has picked up in Dec and it also narrowed down it gap against China Southern Airlines (1055 HK)
  • The resurgence of international traffic over the next two years with more border openings will provide significant benefits to Air China, helping it to recover its depressed load factors.
  • Air China outperformed HSCEI by 3.6pp YTD, but we still consider its P/B of 1.0x, or around historical average, not stretched. Strength of Rmb is also a potential positive factor.

Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

US equity markets ended slightly higher on Friday with the S&P and Nasdaq up 0.1% and 0.6% respectively. Sectoral gains were led by Energy and IT, up 2.5% and 0.9% while losses were led  by Real Estate and Financials, down 1.2% and 1%. US 10Y Treasury yields were up 9bp to 1.79%. European markets were lower on Friday with the DAX, CAC and FTSE down 0.9%, 0.8% and 0.3% respectively. Brazil’s Bovespa was up 1.3%. In the Middle East, UAE’s ADX was flat and Saudi TASI was up 0.3% on Sunday. Asian markets have opened broadly higher following – Shanghai, STI and Nikkei were up 0.6%, 0.1% and 0.8% while HSI was down 0.6%. US IG CDS spreads were 0.3bp wider and HY CDS spreads tighter 0.4bp. EU Main CDS spreads were 1.3bp wider and Crossover CDS spreads were 4.1bp wider. Asia ex-Japan CDS spreads widened 3.5bp.

Morning Views Asia: China South City, Times China

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Wanda Commercial Management Group Pre-IPO – The Positives – Aiming for One of HK’s Largest 2022 IPOs

By Sumeet Singh

  • Wanda Commercial Management Group (WCMG) is looking to raise up to US$4bn in its upcoming Hong Kong IPO.
  • WCMG is a commercial operation service provider. As of Oct 2021, the firm managed 398 malls with total gross floor area (GFA) under management of 56.5m sqm.
  • In this note, we will talk about the positive aspects of the deal.

Shenzhen Chipscreen Biosciences (688321.CH) – Risks Outweigh Opportunities

By Xinyao (Criss) Wang

  • The small market space of peripheral T-cell lymphoma indication and the fierce market competition of other indications, products and candidates make the Company’s future commercialization performance uncertain. 
  • The continuous large investment in R&D, high selling expenses, and declining R&D expending capitalization would further drag down profitability.
  • So, our view is that we are conservative about Chipscreen Biosciences’s outlook at the current stage.

Before it’s here, it’s on Smartkarma

China: Evergrande, Tbea Co Ltd A, Qingdao Ainnovation Technology Group Co Ltd, Akm Industrial, Greenland Hong Kong Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • China Evergrande Group – More Casualties
  • CSI300 Index Rebalance Preview (June 2022): Changes Near the Midway Mark
  • AInnovation Technology IPO Initiation: Code Amber
  • AKM Industrial’s Privatisation Bid
  • Morning Views Asia: Ronshine China Holdings

China Evergrande Group – More Casualties

By Thomas J. Monaco

  • Evergrande Is Breaking Down More Rapidly Than Banks Have Kept Up;
  • Minsheng Has Significant Exposure to Evergrande and Other Problem Developers; and
  • Minsheng Is Not Insolvent, But It Is Getting There Very Quickly.

CSI300 Index Rebalance Preview (June 2022): Changes Near the Midway Mark

By Brian Freitas

  • Nearly midway through the review period for the June rebalance of the Shanghai Shenzhen CSI 300 Index (SHSZ300 INDEX), we see 29 potential changes to the index.
  • There are a lot of high and medium probability changes that could result in a one-way turnover of 4.2% and a one-way trade of CNY 10.17bn at the June rebalance.
  • The potential inclusions have underperformed the potential deletions by c.15% over the last month and this provides a good entry point into a long short/trade.

AInnovation Technology IPO Initiation: Code Amber

By Arun George

  • AInnovation Technology (AIT HK) is a fast-growing enterprise AI solutions provider in China. It is set to launch an HKEx IPO to raise up to US$157 million.  
  • The fundamentals are mixed as diverging growth profiles of key segments, low market share and cash burn are accompanied by a narrowing loss margin. 
  • Overall, we believe the negatives outweigh the positives and we would give the IPO a pass. 

AKM Industrial’s Privatisation Bid

By Arun George

  • Akm Industrial (1639 HK) announced a privatisation offer from Alpha Luck and AKM Meadville at HK$1.82 per scheme share, a 14.47% premium to last full trading day price of HK$1.59. 
  • The key pre-condition is several regulatory approvals which be forthcoming as Alpha Luck is indirectly 100% owned by the SASAC. 
  • The key condition is the scheme approved by at least 75% disinterested shareholders (<10% disinterested shareholders rejection). We think the offer price is reasonable and the scheme will pass. 

Morning Views Asia: Ronshine China Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

China: LG Energy Solution and more

By | China, Daily Briefs

In today’s briefing:

  • ECM Weekly (16th Jan 2022) – LG Energy, Hyundai Engineering, Nippon Paint, Sunac, JL Mag, JREITs

ECM Weekly (16th Jan 2022) – LG Energy, Hyundai Engineering, Nippon Paint, Sunac, JL Mag, JREITs

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • LG Energy Solution (373220 KS) saw very strong demand for its mega US$10bn+ IPO.
  • While other IPO markets were in torpor, a number of placements continued to flow in.

Before it’s here, it’s on Smartkarma

China: Kweichow Moutai, Asia High Yield Bond Index, Kwg Property Holding and more

By | China, Daily Briefs

In today’s briefing:

  • FTSE China A50 Index Ground Rule Change: Big Flows & Large Turnover in March
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers
  • Weekly Wrap – 14 Jan 2022

FTSE China A50 Index Ground Rule Change: Big Flows & Large Turnover in March

By Brian Freitas


Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

US equity markets ended lower with the S&P and Nasdaq down 1.4% and 2.5% respectively. Most sectors were in the red led by IT and Consumer Discretionary down 2.7% and 2.1%. US 10Y Treasury yields were up 1bp to 1.75%. European markets were mixed with the DAX and FTSE up 0.1% and 0.2% while CAC was down 0.5% respectively. Brazil’s Bovespa was down 0.2%. In the Middle East, UAE’s ADX was up 0.7% and Saudi TASI was up 1%. Asian markets have opened broadly lower following losses on Wall Street – Shanghai, HSI and Nikkei were down 0.7%, 0.9% and 1.9% while STI was up 0.4%. US IG CDS spreads were 1.2bp wider and HY CDS spreads also tightened 1.5bp. EU Main CDS spreads were 0.1bp wider and Crossover CDS spreads were 1.9bp tighter. Asia ex-Japan CDS spreads widened 2.2bp.

Weekly Wrap – 14 Jan 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. Shui On Land
  2. Logan Property Holdings
  3. Sino Ocean Land
  4. Tata Motors Ltd
  5. Yuzhou Group

and more…


Before it’s here, it’s on Smartkarma